COVID-19 Vaccine Development Timeline - COVID-19 Clinical Trial
Breaking News | COVID-19

COVID-19 Vaccine Development Timeline

Speed it up The Coalition for Epidemic Preparedness Innovation proposed a truncated process for COVID-19 vaccine development that replaces the lengthy, traditional linear sequence for testing, producing and licensing a vaccine (top). The new approach (bottom) involves running many steps in parallel, including ramping up manufacturing, even before knowing the vaccine will work.

Traditional Vaccine Development

graphic illustrating traditional timeline of vaccine development

Pandemic Pace

graphic illustrating pandemic timeline of vaccine development

Bicycles are the Latest COVID-Related Shortage

If your bike search has ended in empty store shelves, your best bet right now is visiting an independent local bike shop where, yes, you will pay more, but you will get better quality and much better service than at a big-box store.Jason Reser is owner of Reser Bicycle on Monmouth Street in Newport, Kentucky.He says demand has exploded since mid-March, when people were forced to stay home. Being considered an essential business (transportation), and remaining open didn’t hurt either.

“We’ve been getting phone calls, two or three a day, from California, Texas, the East Coast. Basically, some cities are completely out of bikes, and people are calling us,” he said.The reason, he says: people avoiding mass transit, as well as wanting a family activity during the pandemic.



Gilead ups its Donation of the Covid-19 Drug Remdesivir for U.S. Hospitals

Gilead Sciences, the drug company behind the experimental Covid-19 therapy remdesivir, has upped the number of doses it’s donating to the federal government from 607,000 to around 940,000, STAT has learned.

The new number appeared, with no acknowledgement of the shift, in a letter that a U.S. Department of Health and Human Services official sent to governors on Saturday.

Then, on Monday, in a call with leaders of physician and hospital groups, the HHS assistant secretary for preparedness and response explained that the federal agency would receive additional doses of the drug from Gilead in June, according to two participants on the call. Both asked not to be named to ensure continued access to future HHS calls. One said that at least some of the drug would be in a form useful for treating children.

Share this:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on reddit
Reddit
Share on email
Email
Scroll to Top

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.

Want to stay informed?

With an ever-changing situation like COVID-19, it’s important to stay as tuned in as possible. Submit your information below so we can send you periodic updates.